In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis and Idenix Pursue Interdependent Growth

Executive Summary

Novartis has capped a recent dealmaking spree with its most innovative deal yet--a half-acquisition of, half-alliance with, Idenix Pharmaceuticals. The big Swiss company agreed to pay $255 million to acquire a 51% equity stake in the private biotech company.
Advertisement

Related Content

Vertex/J&J: Pushing Big Pharma's Deal Flexibility to the Limit
Vertex/J&J: Pushing Big Pharma's Deal Flexibility to the Limit
Hep C Development Dilemma: Big Money Now or Bigger Money Later?
Hep C Development Dilemma: Big Money Now or Bigger Money Later?
Theravance: Having Cake and Eating It
Theravance: Having Cake and Eating It
Pfizer/Angiosyn: Building Biotechs for Device-style Early M&A
Gilead Gets Triangle, and a Product It Can Leverage
Gilead Gets Triangle, and a Product It Can Leverage
Go to Where the Patients Are

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002108

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel